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Formation of the vascular network by vasculogenesis and angiogenesis is essential for embryonic development, repair and remodeling of tissues in adults, and tumor growth. The angiogenic response to vascular endothelial growth factor (VEGF) and other factors begins with vascular leakage and dissolution of the subendothelial basement membrane, which is followed by the proliferation and migration of vascular endothelial cells 1, 2 . Then, formation of intercellular junctions results in initial sprout formation from existing vessels. The newly formed endothelial tubes mature and become stabilized through their association with mural cells (smooth muscle cells (SMC) and pericytes) 3 . The tightness of the intercellular junctions, particularly adherens junctions composed of VE-cadherin and the associated proteins, controls vascular permeability 4, 5 . Quiescent, stabilized vasculature with intact barrier integrity dominates in the healthy condition. In contrast, in pathological conditions such as tumors, the vasculature is immature and leaky. In the case of vascular insult such as that induced by excessive angiotensin II (Ang II) stimulation, increased vascular permeability is associated with leukocyte infiltration in the vascular wall and vascular disruption 6, 7 . Therefore, stabilization of the vasculature and maintenance of vascular integrity is essential for vascular and tissue homeostasis 8, 9 .
PI3Ks comprise a family of enzymes that phosphorylate membrane inositol lipids at the 3′ position of the inositol ring. The lipid products of PI3Ks serve as important intracellular messengers by interacting with effector proteins, including protein kinases, guanine nucleotide exchangers for G proteins and actin cytoskeleton-regulating proteins. Through these actions, PI3Ks regulate a diverse array of cellular processes [10] [11] [12] . Three classes of PI3Ks exist. Class I PI3Ks, which are activated by tyrosine kinases and G protein-coupled receptors, consist of four catalytic subunits, p110α, p110β, p110γ and p110δ, and produce mainly phosphatidylinositol 3,4,5-trisphosphates (PtdIns(3,4,5)P 3 ). In endothelial cells, class I PI3Ks, in particular p110α, are indispensable for angiogenesis in the early embryo by regulating endothelial cell proliferation, migration and morphogenesis 13, 14 . There is only one class III PI3K, Vps34, which generates PtdIns(3)P to regulate vesicular trafficking and autophagy 15 . In contrast to class I and III PI3Ks, the physiological functions of class II PI3Ks are not well understood. There are three members of the class II PI3K subfamily, which produce mainly PtdIns(3)P in vivo 16, 17 : PI3K-C2α (C2α), PI3K-C2β (C2β) and PI3K-C2γ (C2γ). C2α is distinct from C2β, C2γ and other PI3K isoforms in that it has unique structural features, including a clathrin-binding site in the N-terminal stretch, and relative resistance to PI3K inhibitors 16, 18 . C2α is expressed in a limited number of cell types, including the epithelium, vascular endothelium and smooth muscle 19, 20 . C2α localizes to clathrin-coated endocytic vesicles, other endosomes and the trans-Golgi network (TGN) and has been suggested to regulate intracellular vesicular trafficking 16, 18, 21, 22 . Previous in vitro studies 21, 23, 24 showed that various extracellular stimuli, including cytokines, insulin and integrin ligation, modestly stimulate C2α activity. However, the in vivo function of C2α is largely unknown, although a recent study 25 showed that a hypomorphic C2α mutant allele resulted in impairment of renal glomerular formation.
Using a gene-targeting strategy, we explored the in vivo role of C2α. We found that C2α has a crucial role in developmental and pathological angiogenesis in an endothelial-cell-autonomous manner. Notably, the mechanisms underlying the proangiogenic effects of C2α differ from those of class I PI3Ks: C2α regulates primarily vesicular trafficking, which is essential for normal delivery of membrane proteins, including VE-cadherin, as well as for specific aspects of cellular signaling.
C2α thus has a pivotal role in endothelial cell proliferation, survival, migration, morphogenesis and, thereby, angiogenesis. A second crucial role of C2α in the vasculature is maintenance of endothelial barrier function and vascular integrity.
RESULTS

Endothelial C2a is crucial for physiological angiogenesis
Homozygous global C2α-deleted mutant (Pik3c2a −/− ) mouse embryos had retarded growth from embryonic day (E) 8.5 and died between E10.5-E11.5 as a result of defects in vascular formation (Fig. 1,  Supplementary Table 1 and Supplementary Figs. 1-3) , suggesting an essential nonredundant role of class II PI3Ks in mouse development. Whole-mount CD31 staining of the embryos revealed severe defects in vascular development throughout the embryo (Fig. 1a) . In contrast to wild-type (Pik3c2a +/+ ) embryos, the major vessels, including the dorsal aorta, intersomitic vessels and branchial arches, were severely disorganized or absent in Pik3c2a −/− embryos (Fig. 1a) . We were barely able to detect α-smooth muscle actin (α-SMA)-positive α-SMA-specific immunohistochemical staining in cross sections of dorsal aorta and heart from E11.5 wild-type and Pik3c2a −/− embryos. Scale bars, 100 µm.
(c) Left and middle, gross views and H&E staining of skin sections of E15.5 wild-type and homozygous endothelial-cell-specific C2α-deletion mutant (Pik3c2a ∆EC ) embryos (red arrowheads, dilated vessels and hemorrhage; black arrowheads, normal dermal vessels). Right, whole-mount double immunofluorescence staining of skin sections from E15.5 control and Pik3c2a ∆EC embryos using CD31-specific (red) and α-SMA-specific (green), and VE-cadherin-specific (VEcad, red) and NG2-specific (green) staining. For CD31 and α-SMA staining, white and yellow arrowheads indicate SMCuncovered areas and dettached SMCs, respectively; for VE-cadherin and NG2 staining, yellow and white arrowheads indicate loosely attached and detached pericytes, respectively. a, arteriole; v, venule. Scale bars, 100 µm. (d) Quantification of the CD31-positive vessel area per microscopic field (%) and branch points per vessel area in the skin. n = 6 mice per group. Data shown are the means ± s.e.m., and statistical significance was analyzed by Mann-Whitney U test. (e) CD31-specific and β-galactosidase (βGal)-specific double immunofluorescent staining of brain sections from E15.5 control (Pik3c2a flox/flox ; Rosa26R) and endothelial-cell-specific C2α-deleted (Pik3c2a ∆EC ; Rosa26R) embryos. White arowheads indicate βGal-positive, CD31-negative cord-like cell clusters, which were interspersed within capillaries. Scale bars, 50 µm.
npg mural cells in the Pik3c2a −/− dorsal aorta, but could readily detect such cells in the hearts of Pik3c2a −/− and wild-type embryos (Fig. 1b) . In support of the above data, at midgestation, C2α was highly expressed in vascular endothelial cells, as well as in other cell types, including SMC, cardiomyocytes and gastrointestinal epithelium of wild-type embryos ( Supplementary Fig. 4 ).
To determine in which cell type(s) C2α is required, we generated three cardiovascular-specific C2α deletion strains ( Supplementary  Fig. 5 ). Both SMC-specific (Pik3c2a flox/flox ; SM22a-Cre, called here Pik3c2a ∆SMC ) and cardiomyocyte-specific (Pik3c2a flox/flox ; Nkx2-5-Cre (ref. 26) , called here Pik3c2a ∆CM ) C2α-deletion mutants developed normally and the mutant animals were born at the expected Mendelian ratio (Supplementary Tables 2 and 3) . However, the endothelial-cell-specific C2α-deletion mutant (Pik3c2a flox/flox ; Tie2-Cre (ref. 27 ), called here Pik3c2a ∆EC ) has an embryonic-lethal phenotype (Supplementary Tables 3-7) involving abnormalities in multiple organs, including severely impaired vascular formation, indicating that endothelial C2α is essential for normal vascular formation and development. The most severely affected Pik3c2a ∆EC mutants died at E12.5 and phenocopied a global Pik3c2a-null embryo. Pik3c2a ∆EC embryos also had marked dilation of subcutaneous microvessels and hemorrhage (Fig. 1c) . Double immunofluorescent staining of Pik3c2a ∆EC embryo tissue using CD31-and α-SMA-specific antibodies showed reductions in vascular branching and in the area covered by endothelial cells (reduced by 31% and 36%, respectively, compared with control embryos; P < 0.05; Fig. 1c,d ) and discontinuous and incomplete coverage of microvessels with SMC ( Fig. 1c and Supplementary Fig. 6a,b) . Immunostaining using VE-cadherinspecific and neuron-glial antigen 2 (NG2)-specific antibodies revealed that capillaries had discontinuous adherens-junction formation and poor coverage with NG2-positive pericytes, which were frequently rounded and had cellular processes that were detached from the capillary wall ( Fig. 1c and Supplementary Fig. 6c ). In Pik3c2a ∆EC ; Rosa26R embryos, β-galactosidase-positive, CD31-negative cord-like cell clusters were interspersed within the capillaries (Fig. 1e) , suggesting impaired endothelial-cell differentiation in the vasculature of Pik3c2a ∆EC embryos. Taken together, these results imply that loss of C2α expression in endothelial cells is responsible for the phenotype of Pik3c2a −/− mice.
Because Pik3c2a ∆EC mice are embryonic lethal, we created tamoxifen-inducible, conditional endothelial-cell-specific C2α-deletion mice (Pik3c2a i∆EC ) that expressed tamoxifen-activated Cre recombinase under the control of the VE-cadherin promoter 28 (Pik3c2a flox/flox ; Cdh5(PAC)-CreER T2 ; Supplementary Fig. 5e ). We studied the role of C2α in postnatal physiological angiogenesis in these mice using a retinal angiogenesis model. Administration of tamoxifen to these mice at postnatal day (P) 3 resulted in a marked reduction in C2α protein expression at P6 in endothelial cells isolated from the lungs but not in aortic SMC (Fig. 2a) . At P6, endothelialcell-specific C2α inactivation induced by tamoxifen administration markedly inhibited retinal angiogenesis: vessel area, the number of tip cells and the number of filopodia at the vascularizing front were reduced by 46%, 32% and 48%, respectively, in the superficial layer of retinas from Pik3c2a i∆EC mice compared with those from tamoxifenadministered Pik3c2a flox/flox control mice ( Fig. 2b and Supplementary  Fig. 7 ). Perpendicular vascular sprouting and horizontal vascular network formation in the deeper retina were also severely impaired in Pik3c2a i∆EC retinas (Fig. 2c) Fig. 8 ).
C2a is involved in endothelial cell function through RhoA In human umbilical vein endothelial cells (HUVEC) cultured in serum and growth factor supplement-free medium, knockdown of either p110α or C2α by specific siRNAs, but not knockdown of other PI3Ks by C2β-, Vps34-or p110β-specific siRNAs, inhibited VEGF-Ainduced capillary-like tube formation ( Fig. 3a and Supplementary  Fig. 9a,b) . In HUVEC cultured in complete growth medium with serum and growth-factor supplements (endothelial basal medium 2 (EBM2)), knockdown of C2α inhibited tube formation, whereas knockdown of p110α or other PI3Ks did not have this effect; knockdown of p110α and p110β together inhibited tube formation of cells cultured in EBM2 (Supplementary Fig. 9c ). C2α knockdown also markedly inhibited transwell migration of HUVEC toward VEGF-A (P < 0.001; Fig. 3b ) but not migration of SMC toward platelet-derived growth factor BB (PDGF-BB), augmented HUVEC apoptosis (Supplementary Fig. 9d,e) and modestly inhibited HUVEC serum-induced proliferation ( Supplementary  Fig. 9f ). In contrast, Cre-mediated deletion of C2α had no effect on SMC proliferation (Supplementary Fig. 9g ). These results indicate specific, essential roles for C2α in endothelial cell activities.
C2α silencing did not alter VEGF-A-induced phosphorylation of VEGF receptor 2 (VEGFR2), p42/p44 extracellular signalregulated kinase (ERK), Akt, endothelial nitric oxide synthase (eNOS) or p21-activated kinase-2 (PAK2) (Fig. 3c) , which is in contrast to the effects of p110α knockdown [10] [11] [12] [13] . However, C2α knockdown markedly inhibited VEGF-A-induced phosphorylation of myosin phosphatase target subunit 1 (MYPT1), a substrate of Rho kinase (Fig. 3c,d ), and activation of the small GTPase RhoA (Fig. 3e,f) . Consistent with these results, immunostaining using an antibody that specifically recognizes the GTP-bound active form of RhoA ( Supplementary Fig. 10a ) showed that knockdown of either C2α or p110α suppressed VEGF-A-induced RhoA activation ( Supplementary  Fig. 10b ). Knockdown of C2α but not p110α or Vps34 also inhibited serum and growth factor-induced activation of RhoA ( Supplementary  Fig. 10c ). In addition, C2α knockdown reduced activation of two other small GTPases: Rac1 activation induced by VEGF-A and Rap1 activation induced by fibroblast growth factor 2 (FGF2) ( Supplementary  Fig. 11 ). Both Rac1 and Rap1 as well as RhoA help stabilize VEcadherin at contacts between endothelial cells 5, 29 .
RhoA knockdown, as well as VE-cadherin knockdown, abolished VEGF-A-induced tube formation (P < 0.01; Supplementary  Fig. 12a,b) . In a mixed culture of HUVEC, in which cells expressing the dominant-negative RhoA mutant RhoA Asn19 were mixed with LacZ-transfected control cells, RhoA Asn19 -expressing HUVEC were rounded and did not form cell-cell contacts through cell protrusions as did control HUVEC ( Supplementary Fig. 12c,d ). Together, these observations suggest that C2α has an essential role in endothelial morphogenesis through mechanisms involving RhoA.
C2a is required for endosomal trafficking of VE-cadherin
To study effects of C2α on endosomal trafficking, we first transfected HUVEC with the PtdIns(3)P-specific probe monomeric red fluorescent protein (mRFP)-tagged 2 × FYVE domain 30, 31 . In control HUVEC treated with scrambled (sc) siRNA, the mRFP-2 × FYVE signal was localized mainly to endosomes (Fig. 4a) . Depletion of C2α, but not of p110α or Vps34, markedly reduced the number of mRFP-2 × FYVE + vesicles (P < 0.01). The total cellular content of PtdIns(3)P, but not of PtdIns(3,4)P 2 , PtdIns(3,5)P 2 or PtdIns(3,4,5)P 3 , npg was reduced in C2α-depleted cells compared to control cells (Supplementary Fig. 13 ). Thus, C2α is needed for normal PtdIns(3)P accumulation in the endosomal compartment. Consistent with this idea, we detected C2α in a granular pattern in HUVEC, with enrichment in the perinuclear region, and found that C2α partially colocalized with markers of clathrin-coated vesicles, the TGN and early endosomes ( Supplementary Fig. 14a-c) 16, 18, 22 . The intracellular localization of GFP-C2α also substantially overlapped with that of mRFP-2 × FYVE ( Supplementary Fig. 15a and Supplementary Video 1). The motility, fusion and fission of GFP-tagged 2 × FYVE + vesicles were markedly attenuated in C2α-depleted cells (Supplementary Videos 2 and 3), suggesting that C2α is involved in endosomal trafficking. Knockdown of C2α, but not of p110α or Vps34, caused enlargement of the Golgi and TGN area (Supplementary Fig. 14d ). We also found swelling of the Golgi and TGN compartment in endothelial cells of dorsal aortas from Pik3c2a −/− mice, as assessed by electron microscopy (Supplementary Fig. 14e ). In C2α-depleted but not p110α-or Vps34-depleted HUVEC, the trafficking of VE-cadherin between the TGN and intercellular junctions at the plasma membrane was disrupted (Fig. 4b and Supplementary Videos 4 and 5). C2α was partially colocalized with VE-cadherin in the Golgi and TGN area and in endosomes but this colocalization was not evident at intercellular junctions (Supplementary Fig. 15b) . A portion of the mRFP-2 × FYVE + vesicles were positive for VE-cadherin-GFP, suggesting transport of VE-cadherin by PtdIns(3)P + vesicles (Supplementary Fig. 15c ). In agreement with these findings, the accumulation of VE-cadherin at cell-cell contacts in C2α-depleted but not p110α-or Vps34-depleted HUVEC was reduced and the staining for VE-cadherin was discontinuous ( Supplementary Fig. 16b ). C2α-depleted cells also showed a reduced association of VE-cadherin with β-catenin as well as instability of VE-cadherin protein ( Fig. 4c and Supplementary Fig. 16a) . Expression of RhoA Asn19 in HUVEC impaired VE-cadherin trafficking between the TGN and the plasma membrane, resulting in disturbed VE-cadherin clustering at cell-cell contacts (Fig. 4b,  Supplementary Video 6 and Supplementary Fig. 16c) . In mixed cultures of normal and RhoA-depleted HUVEC, VE-cadherin clustering was impaired at the boundaries between RhoA-depleted cells (Supplementary Fig. 16d) . In C2α-depleted HUVEC, expression npg of a GFP-tagged constitutively active RhoA mutant, Rho Val14 , but not of GFP-tagged wild-type RhoA, partially restored defective VE-cadherin clustering at cell-cell contacts (Supplementary Fig. 16e ). In contrast, in sc-siRNA-treated control HUVEC, expression of GFPtagged RhoA Asn19 , but not of GFP-tagged wild-type RhoA, attenuated VE-cadherin assembly at cell junctions. Thus, RhoA is required for VE-cadherin assembly at the cell junctions of endothelial cells.
As our results indicate that C2α is necessary for endosomal trafficking, and as endosomes are now recognized as being involved in the activation of signaling molecules, including Rho GTPases 32 , we next explored where C2α-dependent RhoA activation occured in cells. We visualized RhoA activation by adopting a fluorescence resonance energy transfer (FRET) imaging technique. We transfected HUVEC with an expression vector for a chimeric RhoA-FRET probe protein, proMMP-2 and proMMP-9, MMP-2 and MMP-9 proenzymes; actMMP-2 and actMMP-9, active MMP-2 and MMP-9. Right, quantification of MMP-2 and MMP-9 activities. The sum of the proMMP-2 and actMMP-2 band densities and the sum of the proMMP-9 and actMMP-9 band densities were defined as MMP-2 and MMP-9 total activities, respectively. n = 6 mice per group. Data shown are means ± s.e.m. Statistical significance was analyzed by MannWhitney U test. (j) Mac-3-specific immunohistochemical staining of the aortic walls of male Pik3c2a +/+ and Pik3c2a +/− 10-week-old mice treated with Ang II. Red arrowheads, infiltrating macrophages; black arrows, internal elastic lamina; yellow arrows, external elastic lamina. Scale bar, 200 µm.
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Raichu-RhoA, which comprises N-terminal yellow fluorescent protein (YFP), the Rho-binding domain of protein kinase N, RhoA and C-terminal cyan fluorescent protein (CFP). GTP loading into the RhoA domain of Raichu-RhoA protein results in an intramolecular conformational change of Raichu-RhoA, which increases FRET efficiency. By fluorescent microscopic observation, we could localize RhoA activation sites within cells. In HUVEC, RhoA was activated in both the intracellular vesicular compartment and the plasma membrane, with intense signals at cell-cell contacts (Fig. 4d and Supplementary Video 7) . A substantial portion of the intracellular FRET signal coincided with mRFP-2 × FYVE signals (Fig. 4e) . C2α knockdown reduced the RhoA FRET signal in both the endosomes and the plasma membrane (Fig. 4d-g and Supplementary Video 8) , indicating that C2α is necessary for RhoA activation in PtdIns(3)P-enriched endosomes and in the plasma membrane. We further studied the role of C2α in VEGF receptor internalization, which might occur upstream of RhoA activation 33 . VEGF-A stimulated the internalization of VEGFR2 into the 2 × FYVE + vesicular compartment, which was dampened by C2α depletion (Fig. 4h) . VEGF-A induced phosphorylation of VEGFR2 at the plasma membrane 2 min after stimulation; at 30 min after stimulation, most phosphorylated VEGFR2 was redistributed in the intracellular compartment, primarily in early endosome antigen 1 (EEA1) + endosomes (Supplementary Fig. 17 ). C2α depletion did not inhibit the initial VEGFR2 phosphorylation in the plasma membrane but did inhibit the internalization of phosphorylated VEGFR2 (Supplementary Fig. 17) . Furthermore, treatment with dynasore, an inhibitor of dynamin-dependent endocytosis 34 , inhibited growthfactor-induced RhoA activation, VE-cadherin assembly at cell junctions and tube formation ( Supplementary Fig. 18a-d) . Thus, C2α is essential for the internalization of activated VEGF receptors, activation of RhoA and other signaling molecules on endosomes, RhoA-dependent trafficking and assembly of VE-cadherin at cell junctions.
Endothelial C2a is essential for pathological angiogenesis
We next studied the role of endothelial C2α in pathological angiogenesis using postischemic and tumor angiogenesis models. In Pik3c2a i∆EC mice, the recovery of blood flow in the ischemic hindlimb after surgical femoral arteriectomy was suppressed during postoperative days 14-28 compared to the recovery in control Pik3c2a flox/flox mice (P < 0.0001 on day 28; Fig. 5a ). Immunofluorescence staining using a CD31-specific antibody showed an approximately 50% decrease in microvessel density in the ischemic muscle of Pik3c2a i∆EC mice compared to control mice on postoperative day 28 (P < 0.0001; Fig. 5b ).
After implantation of Lewis lung carcinoma (LLC) or B16-BL6 melanoma tumors, Pik3c2a i∆EC mice had diminished tumor volumes and weights compared with those of control Pik3c2a flox/flox mice (P < 0.05; Fig. 5c ). The microvessel density in LLC tumors was reduced in Pik3c2a i∆EC mice compared to that in control mice (P < 0.05; Fig. 5d) . Moreover, double immunostaining with CD31-and NG2-specific antibodies revealed that tumor microvessels in Pik3c2a i∆EC mice had poor coverage with NG2 + pericytes, which were frequently rounded or detached from the microvessels (Fig. 5e) .
C2a is required for vascular barrier function and integrity
The permeability of a monolayer of C2α-depleted HUVEC was increased under both resting and VEGF-A-stimulated conditions compared with that of control cells under the same conditions (P < 0.05; Fig. 6a) . After VEGF-A injection, the increase in the leakage of intravenously administered Evans blue dye into the skin was greater in Pik3c2a +/− mice than in wild-type mice (P < 0.05; Fig. 6b) . We next studied vascular responses to other hyperpermeability-and inflammation-eliciting insults in global Pik3c2a +/− and wild-type mice. Intravenous (i.v.) injection of a low dose of platelet-activating factor (PAF), a mediator of anaphylactic shock 35 , did not affect survival in wild-type mice, whereas it induced death in all Pik3c2a +/− littermates within 40 min, with accompanying increases in hematocrit levels and Evans blue leakage in the lung (Fig. 6c,d) . A higher dose of PAF, which induced death in a portion (about 30%) of wild-type mice, caused more rapid death of all Pik3c2a +/− mice (Fig. 6c) . PAF-induced increases in plasma histamine and interleukin-4 (IL-4) concentrations, both of which are anaphylactic mediators, were similar in wildtype and Pik3c2a +/− mice (Supplementary Fig. 19 ), suggesting that C2α deficiency impairs endothelial function, resulting in vascular barrier disruption.
Chronic Ang II infusion induced more robust hyperpermeability in the aorta and coronary vessels in Pik3c2a +/− mice than in wild-type littermates (Fig. 6e) . En face immunostaining of the aorta using a VE-cadherin-specific antibody showed disorganization of adherens junctions in AngII-treated Pik3c2a +/− mice (Fig. 6f) . Concomitantly, we found a higher incidence of aortic aneurysms with dissection, resultant rupture and death in Pik3c2a +/− mice compared with wildtype littermates (aneurysm occurred in 23/48 Pik3c2a +/− mice and 5/44 wild-type mice) (P < 0.01; Fig. 6g,h) . Conditional endothelialcell-specific deletion of C2α also resulted in a higher occurrence of dissecting aneurysms compared to control mice (aneurysm occurred in 5/20 Pik3c2a i∆EC mice and 1/13 control mice) (P < 0.01; Fig. 6g ). There was no difference in blood pressure between AngII-treated Pik3c2a-deleted and control mice (data not shown). Thus, the aortic walls of C2α-deficient mice seem to be fragile compared with those of wild-type mice. Ang II infusion stimulated matrix metalloproteinase 2 (MMP-2) and MMP-9 activities, which have been implicated in the formation of aneurysms in aortic tissue 6, 7, 36, 37 ; these increases were greater in Pik3c2a +/− mice than in wild-type mice (P < 0.05; Fig. 6i) . Immunostaining using an antibody to Mac-3, a macrophage marker, revealed a greater number of infiltrating macrophages (the major source of MMPs), found primarily in the aortic adventitia, in Pik3c2a +/− mice compared with wild-type mice (Fig. 6j) .
DISCUSSION
This study shows that in endothelial cells, PI3K-C2α, a class II PI3K, has indispensable roles in sprouting angiogenesis and subsequent mural-cell recruitment and in maintaining vascular barrier integrity in quiescent vessels. C2α deficiency results in impaired angiogenesis and pathological vascular hyperpermeability with vascular damage. At the cellular level, C2α is essential for endothelial cell migration, proliferation and survival and VE-cadherin assembly at intercellular junctions. The actions of C2α are mediated by its regulatory effects on intracellular vesicular transport; that is, on the delivery and recycling of membrane molecules and on cell signaling that likely occurs on endosomes (Supplementary Fig. 20 ). These actions of C2α underlie its roles in angiogenesis and barrier integrity. The actions of C2α and of class I PI3Ks in endothelial cells are distinct: in contrast to C2α, class I PI3Ks have a large effect on Akt stimulation and cell proliferation but are not involved in vesicular trafficking and do not affect VE-cadherin trafficking to the plasma membrane or VE-cadherin assembly at the cell-cell junction [10] [11] [12] [13] . Therefore, these observations reveal new biological activities of C2α and underscore broader roles for PI3K family members in vascular physiology and pathophysiology.
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In contrast to class I PI3Ks that generate PtdIns(3,4,5)P 3 , the major product of class II and III PI3Ks is PtdIns(3)P, which accumulates mainly in endosomes [16] [17] [18] [20] [21] [22] [23] [24] [25] . Consistent with this, C2α in endothelial cells was localized in endosomes and the TGN, organelles that are responsible for the processing, sorting and packaging of proteins for transport to their final destinations. Another class II PI3K, PI3K-C2β, and the class III PI3K Vps34 are also localized primarily in the clathrin-coated or endocytic compartment 38, 39 . Localized production of PtdIns(3)P in conjunction with the presence of Rab GTPases, such as Rab5, on the endocytic membrane cause the recruitment of proteins such as EEA1 and rabenosyn-5; this recruitment facilitates dynamic formation of endocytic membranous structures for uptake, packaging and sorting 31, 32, 39 . Our results show that C2α is the PI3K isoform in endothelial cells that is largely responsible for PtdIns(3)P accumulation on endosomes. C2α seems to have a functionally distinct role from that of C2β or Vps34, as depletion of C2α, but not Vps34 or C2β, severely impairs trafficking of 2 × FYVE + vesicles and transport and assembly of VE-cadherin, and C2α deficiency impairs receptor internalization and VE-cadherin trafficking. Thus, C2α in endothelial cells may be located in a different endocytic compartment compared to C2β and Vps34 cells, or C2α activity may be regulated differently compared to the activities of C2β and Vps34 (refs. 18,23,40) . Therefore, C2α has specialized functions in vesicular trafficking in endothelial cells.
Our data also show that C2α is involved in cell signaling. Endocytosis has long been recognized as a mechanism for terminating signaling by internalizing and degrading cell-surface receptors 41 . Besides this classical role of endocytosis, recent studies 32, [41] [42] [43] have shown that endosomes serve as platforms to assemble membrane receptors and their downstream signaling molecules and to generate spatially localized signals. In endothelial cells, activation of RhoA, Rac1 and Rap1, but not of Akt or ERK, is dependent on C2α to varying degrees, indicating that the generation of certain intracellular signals requires C2α. In particular, C2α is essential for the internalization of activated VEGFR2 and endosomal RhoA activation. Consistent with the role of endosomes in receptor signaling, blockade of endocytosis suppressed VEGF-A-induced RhoA activation. Localized activation of RhoA was recently shown to be necessary for the proper assembly of VE-cadherin at intercellular junctions and for barrier-protective activity 44, 45 , although there is also evidence for an opposite barrier-disruptive activity of RhoA 4, 46, 47 . Our data indicate that C2α-dependent RhoA activity on endosomes is crucial for the delivery and assembly of VE-cadherin at cell contacts and for cell-cell contact formation. The identity of the Rho-guanine nucleotide exchange factor (Rho-GEF) that is responsible for VEGFinduced endosomal RhoA activation in endothelial cells, as well as the molecular mechanisms involved in the recruitment and activation of this factor, remain to be determined. Rap1 and Rac1 have also been implicated in strengthening VE-cadherin-mediated intercellular junctions 4, 46, 48 .
The effects of C2α on endosomal transport and signaling may have a pivotal role in endothelial cell migration, proliferation and survival and vascular morphogenesis. For example, Rho and Rac are activated at the rear and front ends, respectively, of migrating cells to drive machinery responsible for retracting the rear portion of the cell body and extending protrusions forward 49 . During cell migration, there is assembly and disassembly of focal adhesions, which depends on endocytic and recycling vesicular functions 49, 50 . Rho GTPases are involved in the formation of focal adhesions, which generate cellsurvival signals through mechanisms involving integrin ligation.
Polarization of the endothelial cell monolayer in the vascular wall also depends on membrane trafficking 51 . Endosomes could be involved in these processes, both by serving as a platform for the activation of Rho GTPases and recruiting Rho GTPases to specific sites within cells 45 . Taken together, our observations strongly suggest that C2α has a role in angiogenesis and vascular integrity through its regulation of vesicular trafficking.
In adult mice, C2α expression is generally diminished compared with its expression in embryos, but it is still expressed at an easily detectable level in the vascular endothelium among other tissues 19 . Our data show that C2α is essential for maintaining barrier integrity in quiescent vessels, as evidenced by its protective role in diminishing VEGF-A-induced hyperpermeability. In anaphylaxis, a 50% reduction in C2α expression markedly increased mortality. In chronic vascular injury induced by Ang II infusion, disruption of the vascular wall probably caused by disassembly of VE-cadherin in the endothelium occurs, leading to fatal dissecting aneurysm formation. Collectively, our data are consistent with the notion that a normal level of C2α expression is essential for the maintenance of vascular integrity in quiescent vasculature, as well as for neovesssel formation. These observations point to the possibility that C2α may be a new therapeutic target for vascular diseases caused by barrier disruption.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
filopodial bursts in arterial zones per unit area in the flat-mount retina was counted from 15-20 randomly defined microscopic fields from 5-8 retinas per group for each genotype. The values were normalized by field size. For labeling of proliferating cells in the retina, 300 µg of BrdU (BD) in 100 µl PBS per pup was i.p. injected 2 h before euthanasia. After isolectin B4 staining, retinas were stained with BrdU-specific antibody (1:100, BD, 555627). Postischemic hindlimb angiogenesis model. Male Pik3c2a i∆EC mice and control Pik3c2a flox/flox littermates (C57BL/6 background) were subjected to surgical procedures to achieve unilateral hindlimb ischemia, as described previously 57 . In brief, the femoral artery was exposed and ligated with 8-0 silk, and the whole length of the femoral artery was excised. The blood flow of the ischemic (left) and contralateral nonischemic (right) hindlimbs was measured with a laser Doppler blood flow (LDBF) analyzer (Moor Instruments) before and after operation. The stored data were analyzed to quantify the mean LDBF per unit of twodimensional area on the en face image of each entire hindlimb in mice in the supine position, which was determined using software provided by the manufacturer (Moor Instruments). For each mouse, results were expressed as the ratio of the LDBF value in the ischemic (left) limb to the value in the nonischemic control (right) limb at a given time point.
Tumor angiogenesis model. LLC cells (1 × 10 6 ) or B16-BL6 melanoma cells (5 × 10 5 ) were subcutaneously implanted in the dorsal backs of 8-to 10-week-old male Pik3c2a i∆EC mice and control Pik3c2a flox/flox littermates (C57BL/6 background) 58 . Tumor volumes were calculated by the formula V = (LW 2 )/2, where L and W denote the longer and shorter diameter, respectively.
PAF-induced anaphylaxis model. To trigger anaphylactic shock, 10-to 12-week-old male Pik3c2a +/− or littermate wild-type mice received i.v. injection of PAF (12 µg per kg body weight or 20 µg per kg body weight in 100 µl saline) in the tail vein, and their survival was followed. In separate mice, 15 min after infusion, blood samples were obtained from the right ventricle to determine hematocrit content. To assess vascular leakage in the lung, 100 µl of a 1% solution of Evans blue dye in saline was injected into the tail vein together with PAF. Fifteen minutes later, mice were perfused with saline in the right ventricle to remove the intravascular Evans blue dye. The lungs were excised and extracted in 1 ml of formamide at 55 °C overnight. Evans blue content was determined by the equation: corrected 620-nm optical density (OD 620 (Evans blue) − (1.426 × OD 740 (hemoglobin) + 0.03).
Ang II infusion aortic aneurysm model. An osmotic minipump (Alzet, model 1002) containing Ang II (Calbiochem, 1.0 mg per kg body weight per day) was implanted in the midscapular region in male Pik3c2a +/− or Pik3c2a i∆EC and wild-type littermates. Mice were euthanized at day 14 after minipump implantation, and aortic tissue was removed. Aneurysm severity was graded according to the following criteria 59 : grade 1, remodeled tissue in the suprarenal region frequently containing thrombus; grade 2, pronounced bulbous form of grade 1 containing thrombus; grade 3, multiple aneurysms containing thrombus; or ruptured, ruptured aortic aneurysm. Both cryostat and paraffin-embedded aortic sections were used for the characterization of aneurysmal lesions. Elastin was visualized using Elastica van Gieson staining. Fibrosis was evaluated using Azan staining. Infiltrating macrophages were detected using Mac-3-specific antibody (1:400, BD, 553322) immunostaining. Miles assay and gelatin zymography were performed as described below.
Live-cell imaging and FRET analysis. Cells transfected with expression vectors for GFP-C2α, GFP-or mRFP-2 × FYVE and VE-cadherin-GFP or -mRFP were plated on collagen-coated glass-bottomed dishes (MatTek, P35G-1.5-20-C) or LabTek chamber slides (Thermo Scientific, 177402) and allowed to adhere for 16 h before imaging. Cells on a heated stage (37 °C; Tokai-Hit) were observed under a custom confocal microscope based on an inverted IX70 microscope (Olympus) equipped with an UPLSAPO ×60/NA1.35-oil or ×40/0.95-oil objective, a confocal laser unit (CSU10, Yokogawa), an electron multiplying charge-coupled device (EMCCD) digital camera (iXon, Andor) and a Light engine (Lumencor, Inc) for three-dimensional time-lapse confocal imaging at a rate of two frames per second. The acquisition and process were controlled by iQ software (Andor).
For FRET analysis, HUVEC were transfected with the pRaichu-RhoA FRET probe vector (provided by M. Matsuda at Kyoto University) using an Amaxa Nucleofector system (Lonza) and imaged using a custom confocal microscope system configured with a CFP and YFP filter set (Di01-T445/515/561-13 × 15 × 0.5, Semrock). Pseudograyscale ratio images were generated from images from the CFP and FRET channels using Andor iQ software.
Cell proliferation, migration, adhesion, apoptosis and tube-formation assay. Cell proliferation was analyzed using an MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt) assay kit (Promega) according to the manufacturer's instructions. For the modified Boyden chamber cell migration assay, siRNA-transfected HUVEC (5 × 10 4 cells per well) resuspended in M199 medium (Gibco) containing 0.25% fatty-acid-free BSA (Sigma-Aldrich) or adenovirus-infected MASM cells (2 × 10 4 cells per well) resuspended in serum-free DMEM were placed in the upper chamber and allowed to migrate across collagen type I-coated polycarbonate filters (8-µm pore size, Neuro Probe) for 6 h toward the lower chamber with or without VEGF-A (0.5-100 ng ml −1 ) for HUVEC and with or without PDGF-BB (0.1-30 ng ml −1 ) for MASM. The cells remaining on the upper surface of the transwell membranes were removed, and the cells that had migrated to the lower surface were methanol fixed, stained with Diff-Quick (Sysmex) and counted in five random microscopic fields. To analyze cell adhesion to a collagen-covered surface, HUVEC that had been transfected with scrambled (control) or C2α-siRNAs were seeded onto 96-well tissue culture plates coated with collagen type I and incubated in the presence of VEGF-A (30 ng ml −1 ) for the indicated time periods. After washing with PBS three times to remove nonadherent cells, adherent cells were stained with Diff-Quick and quantified in triplicates with a microplate reader (Bio-Rad). To assay apoptosis, cells were immunostained with cleaved caspase-3-specific antibody (1:1,000, Cell Signaling, 9664) according to the manufacturer's instructions (Cell Signaling). To assay tube formation, siRNA-transfected HUVEC (2.5 × 10 4 cells) in EBM2 containing 2% FBS with or without supplements were seeded onto 200 µl of growth-factor-reduced Matrigel in a 24-well plate in the absence or presence of VEGF-A (30 ng ml −1 ) and incubated for 12-16 h. Tube formation was quantified after 12-16 h by measuring the cumulative tube length and number of branching points in five random microscopic fields using ImageJ (NIH).
Pulldown assay of small G protein activity. The pulldown assays for GTP-bound RhoA, Rac1 and Rap1were performed as described previously 60 . In brief, confluent HUVEC were stimulated and lysed with either Rho extraction buffer (50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 10 mM MgCl 2 , 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 10% glycerol and protease and phosphatase inhibitor cocktail (Roche)), Rac extraction buffer (50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 10 mM MgCl 2 , 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 10% glycerol and protease inhibitor cocktail) or Rap extraction buffer (20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM MgCl 2 , 1% NP-40, 1 mM EGTA and protease inhibitor cocktail). The lysates were cleared by centrifugation, and the resultant supernatants were incubated for 60 min at 4 °C with glutathioneSepharose 4B beads coupled to the Rho binding domain of Rhotekin for RhoA, the PAK1-CRIB domain for Rac1 or the Rap-binding domain of Ral-GDI for Rap1. The beads were washed and bound proteins were solubilized by the addition of 30 µl of SDS-PAGE 2 × Laemmli's loading buffer, followed by separation on 15% SDS-PAGE gels and western blotting with RhoA-specific (1:1,000, Santa Cruz sc-418, 26C4), Rac1-specific (1:2,000, Millipore 05-389, 23A8) and Rap1-specific (1:1,000, BD, 610195) antibodies, respectively.
In vitro transwell and in vivo Miles permeability assay. HUVEC transfected with C2α-siRNA or sc-siRNA were seeded onto collagen-coated transwells with a 0.4-µm pore size (Costar) and allowed to form a monolayer. Permeability was stimulated with VEGF-A 165 (50 ng ml −1 ) or thrombin (0.5 U ml −1 ) for 30 min, followed by the addition of FITC-dextran (at a final concentration of 1 mg ml −1 ) (molecular mass (Mr) = 42 kDa; Sigma-Aldrich) into the top chamber followed by incubation for an additional 30 min. The amount of FITCdextran in the bottom chamber was determined by fluorometric analysis.
To assay in vivo permeability, 1.0% Evans blue dye in saline (100 µl) was i.v. injected into the tail vein of Pik3c2a +/+ and Pik3c2a +/− mice and allowed to npg circulate for 20 min. Recombinant human VEGF-A 165 (100 ng ml −1 , 100 µl; PeproTech) or PBS was injected intradermally into the preshaved back skin. After 20 min, the mice were euthanized, and the area of skin that included the entire injection site was removed. For the Ang II infusion model, 100 µl of a 1% solution of Evans blue dye in saline was injected into the tail veins of male Pik3c2a +/− mice or Pik3c2a +/+ littermates that had received Ang II infusion for 14 d prior (1.0 mg per kg body weight per day). Thirty minutes later, mice were perfused with saline in the right ventricle to remove intravascular Evans blue dye, and the heart and aorta tissues were excised. Evans blue dye was extracted from the tissues by incubation with formamide overnight at 55 °C, and Evans blue content was determined spectrophotometrically as described above.
Metabolic cell labeling, lipid extraction and phosphoinositide measurements. The amounts of cellular phosphoinositides were determined as described previously 61 . In brief, MEF were labeled for 48 h with 10 µCi ml −1 [ 3 H]-myo-inositol (Amersham Biosciences) in inositol-free DMEM containing 10% FBS. Labeling was quenched and lipids were extracted as described 61 . Dried lipids were deacylated and analyzed by HPLC using a Partisphere SAX column (Whatman). Radioactivity was measured in 0.5 ml fractions using a liquid scintillation counter.
Statistical analyses.
Unless otherwise noted, data are presented as means ± s.e.m. and were analyzed using Prism 5 software (GraphPad Software Inc). Paired data were compared by two-tailed Student's t test or Mann-Whitney nonparametric U test. Comparisons between multiple groups were analyzed by one-or two-wayANOVA followed by Bonferroni's post-hoc test. For the KaplanMeier curves, P values were determined with a log-rank Mantel-Cox test.
Results with P < 0.05 were considered statistically significant. The presented data represent at least three independent experiments. Additional methods. Additional methodology is described in the online Supplementary Methods.
